Universal Health Realty Income Trust Common Stock (UHT)

FairStock Score: 43/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for durable cash rents and a balance sheet that can survive tight times. UHT owns 77 healthcare-related properties across 21 states, and its latest filed quarter, fiscal Q2 2026, the quarter ended 2026-06-30, showed revenue of $25.0M and net income of $5.9M, a 23.64% margin. That is a decent quarter, but the long-term record is sluggish: FY2025 revenue was $99.2M versus $99.0M in FY2024, while net income fell to $17.6M from $19.2M. FairStock categorizes it as a slow grower whose profits have shrunk about 2.0% a year over five years. As a REIT, EPS is distorted by depreciation, and FFO/AFFO, the right measures, are not in the data. So I lean on the 7.54% dividend yield at the 2026-10-13 close, but note leverage: debt-to-equity of 2.75 and ROCE of only 4.15%. The shares at $37.81 on 2026-10-13 trade at 3.65 times book and 27.20 times FairStock EPS, not obviously cheap. FCF yield of 9.2% and Piotroski 6/9 offer some support, while Altman 2.41 is middling. This is a steady toll-road-like portfolio with a narrow moat at best: specialized healthcare properties can be hard to replace, but the trust has limited pricing power if tenants struggle. Growth trajectory is modest. Income is the main attraction; the price seems full unless FFO/AFFO prove stronger.

In plain English: Universal Health Realty Income Trust owns healthcare buildings and hospitals, and it makes money by collecting rent. The business looks stable but not fast-growing: sales have barely moved and profits have bounced around. At the recent price, the shares look full rather than cheap compared with the company's profits and accounting value.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer